{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T05:00:14Z","timestamp":1790312414801,"version":"4.1.0"},"reference-count":31,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:00:00Z","timestamp":1790294400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      No single imaging modality currently provides quantitative assessment of disease activity in active charcot neuro-osteoarthropathy (CNO) of the foot, either at diagnosis or during follow-up after clinical remission. This study evaluates the role of\n                      <jats:sup>18<\/jats:sup>\n                      F-sodium fluoride positron emission tomography\u2013computed tomography (\n                      <jats:sup>18<\/jats:sup>\n                      F-NaF PET\/CT) in active CNO.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      In this prospective study, 80 patients with diabetes presenting with asymmetric foot swelling were screened and assessed using an infrared thermometer. 39 symptomatic patients were included (33 active CNO and 6 non-CNO) and underwent magnetic resonance imaging (MRI) and\n                      <jats:sup>18<\/jats:sup>\n                      F-NaF PET\/CT. 20 additional participants (10 diabetic neuropathy and 10 healthy controls) underwent PET\/CT for assessing the uptake in diabetic patients and normal individuals. Standardized uptake value maximum (SUVmax) on\n                      <jats:sup>18<\/jats:sup>\n                      F-Sodium Fluoride PET-CT was measured at the region of interest (ROI) of affected foot at baseline, clinical remission, and three-monthly post-remission. Change in SUVmax from baseline to clinical remission was compared between patients with sustained remission and those with relapse. Exploratory univariate Cox regression analysis was performed to assess associations between SUVmax changes and recurrence.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Median SUVmax (baseline) was 55.1 in active CNO versus 7.5 in non-CNO (p&amp;lt;0.001). An SUVmax value of \u226510.3 yielded 100% sensitivity (95% CI 89.4\u2013100%) and 92.3% specificity (95% CI 74.9\u201399.1%) against all controls (AUC 0.988, 95% CI 0.965\u20131.000); specificity was 66.7% against symptomatic non-CNO patients. 29 participants achieved clinical remission, and SUVmax decreased from 58.3 to 19.6 (61.9% reduction; p&amp;lt;0.001). 4 patients with active CNO relapse showed significantly lower SUVmax reduction than those with sustained remission (28.4% vs 64.7%, p=0.006). In exploratory analysis, greater reduction in SUVmax between baseline and clinical remission was associated with lower recurrence risk (HR 0.970 per 1% greater reduction, 95% CI 0.941\u20130.999). With only four events, this finding is hypothesis-generating.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      <jats:sup>18<\/jats:sup>\n                      F-NaF PET\/CT shows promise as a quantitative marker of bone remodelling in active CNO in patients with diabetes. These findings are exploratory and require external validation in large cohorts.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2026.1930281","type":"journal-article","created":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T04:28:10Z","timestamp":1790310490000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Quantitative assessment of active charcot neuro-osteoarthropathy in diabetes using 18F-sodium fluoride PET\/CT"],"prefix":"10.3389","volume":"17","author":[{"given":"Jayaditya","family":"Ghosh","sequence":"first","affiliation":[{"name":"Department of Endocrinology, Post Graduate Institute of Medical Education and Research","place":["Chandigarh, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashu","family":"Rastogi","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Post Graduate Institute of Medical Education and Research","place":["Chandigarh, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avanthiga","family":"Subrhamanian","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Post Graduate Institute of Medical Education and Research","place":["Chandigarh, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harmandeep","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Post Graduate Institute of Medical Education and Research","place":["Chandigarh, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anindita","family":"Sinha","sequence":"additional","affiliation":[{"name":"Department of Radiodiagnosis, Post Graduate Institute of Medical Education and Research","place":["Chandigarh, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raghuraman","family":"Soundararajan","sequence":"additional","affiliation":[{"name":"Department of Radiodiagnosis, Post Graduate Institute of Medical Education and Research","place":["Chandigarh, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pinaki","family":"Dutta","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Post Graduate Institute of Medical Education and Research","place":["Chandigarh, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay Kumar","family":"Bhadada","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Post Graduate Institute of Medical Education and Research","place":["Chandigarh, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0030-1254525","article-title":"Neuro-osteoarthropathy of the foot-radiologist: friend or foe","volume":"14","author":"Schoots","year":"2010","journal-title":"Semin Musculoskelet Radiol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"21","DOI":"10.7547\/21-122","article-title":"Ankle Charcot mimics: Tubercular rheumatism to complex regional pain syndrome","volume":"112","author":"Rastogi","year":"2022","journal-title":"J Am Podiatr Med Assoc"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.3646","article-title":"Guidelines on the diagnosis and treatment of active Charcot neuro-osteoarthropathy in persons with diabetes mellitus (IWGDF 2023)","volume":"40","author":"Wukich","year":"2024","journal-title":"Diabetes Metab Res Rev"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1177\/1071100712464957","article-title":"Recurrence of acute Charcot neuropathic osteoarthropathy after conservative treatment","volume":"34","author":"Osterhoff","year":"2013","journal-title":"Foot Ankle Int"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdiacomp.2012.05.006","article-title":"Duration of off-loading and recurrence rate in Charcot osteo-arthropathy treated with less restrictive regimen with removable walker","volume":"26","author":"Christensen","year":"2012","journal-title":"J Diabetes Complications"},{"key":"B6","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.foot.2006.11.004","article-title":"Role of 99mTc MDP bone and 67Gallium imaging in evaluation of diabetic osteopathy","volume":"17","author":"Shanmuga Sundaram","year":"2007","journal-title":"Foot"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1236881","article-title":"Utility of a simplified [18F] sodium fluoride PET imaging method to quantify bone metabolic flux for a wide range of clinical applications","volume":"14","author":"Puri","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.4414\/smw.2014.13948","article-title":"Is the Eichenholtz classification still valid for the diabetic Charcot foot","volume":"144","author":"Chantelau","year":"2014","journal-title":"Swiss Med Wkly"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.795925","article-title":"Novel application of 18F-NaF PET\/CT imaging for evaluation of active bone remodeling in diabetic patients with Charcot neuropathy: A proof-of-concept report","volume":"9","author":"Puri","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.2967\/jnmt.116.176859","article-title":"The role of 18F-sodium fluoride PET\/CT bone scans in the diagnosis of metastatic bone disease from breast and prostate cancer","volume":"44","author":"Kulshrestha","year":"2016","journal-title":"J Nucl Med Technol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.5114\/pjr.2022.116637","article-title":"The role of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging for the diagnosis of diabetic foot osteomyelitis: a preliminary report","volume":"87","author":"Raj","year":"2022","journal-title":"Pol J Radiol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1007\/s00592-019-01376-9","article-title":"Mortality in Asian Indians with Charcot's neuroarthropathy: a nested cohort prospective study","volume":"56","author":"Chaudhary","year":"2019","journal-title":"Acta Diabetol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-5491.2010.03141.x","article-title":"The consequences of complacency: managing the effects of unrecognized Charcot feet","volume":"28","author":"Wukich","year":"2011","journal-title":"Diabetes Med"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1177\/1071100716649173","article-title":"Correlation of systemic inflammatory markers with radiographic stages of Charcot osteoarthropathy","volume":"37","author":"Hingsammer","year":"2016","journal-title":"Foot Ankle Int"},{"key":"B15","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s13244-019-0768-9","article-title":"The Charcot foot: a pictorial review","volume":"10","author":"Rosskopf","year":"2019","journal-title":"Insights Imaging"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1177\/20420188231160406","article-title":"Controversies in the management of active Charcot neuroarthropathy","volume":"14","author":"Gooday","year":"2023","journal-title":"Ther Adv Endocrinol Metab"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1302\/2058-5241.3.180003","article-title":"The acute Charcot foot in diabetics: Diagnosis and management","volume":"3","author":"Yousaf","year":"2018","journal-title":"EFORT Open Rev"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3402\/dfa.v3i0.18754","article-title":"Current challenges in imaging of the diabetic foot","volume":"3","author":"Sanverdi","year":"2012","journal-title":"Diabetes Foot Ankle"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/s0033-8389(03)00163-5","article-title":"MR imaging of the diabetic foot","volume":"9","author":"Morrison","year":"2001","journal-title":"Magn Reson Imaging Clin N Am"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1111\/cpf.12264","article-title":"Three-phase bone scintigraphy for diagnosis of Charcot neuropathic osteoarthropathy in the diabetic foot - does quantitative data improve diagnostic value","volume":"37","author":"Fosb\u00f8l","year":"2017","journal-title":"Clin Physiol Funct Imaging"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1186\/1757-1146-6-30","article-title":"Developing an evidence-based clinical pathway for the assessment, diagnosis and management of acute Charcot neuro-arthropathy: a systematic review","volume":"6","author":"Milne","year":"2013","journal-title":"J Foot Ankle Res"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1097\/mnm.0b013e328174447f","article-title":"Potential role of FDG PET in the setting of diabetic neuro-osteoarthropathy: can it differentiate uncomplicated Charcot's neuroarthropathy from osteomyelitis and soft-tissue infection","volume":"28","author":"Basu","year":"2007","journal-title":"Nucl Med Commun"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24033014","article-title":"RANKL-RANK-OPG pathway in Charcot diabetic foot: Pathophysiology and clinical-therapeutic implications","volume":"24","author":"Greco","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B24","doi-asserted-by":"publisher","first-page":"20130444","DOI":"10.1259\/bjr.20130444","article-title":"Comparison of 18F-fluoride PET\/CT, 18F-FDG PET\/CT and bone scintigraphy (planar and SPECT) in detection of bone metastases of differentiated thyroid cancer: a pilot study","volume":"87","author":"Ota","year":"2014","journal-title":"Br J Radiol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s40001-025-02278-z","article-title":"Infrared thermography in clinical practice: a literature review","volume":"30","author":"Liu","year":"2025","journal-title":"Eur J Med Res"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1002\/jfa2.70016","article-title":"Factors associated with the development of recurrent and contralateral Charcot neuroarthropathy in individuals with diabetes mellitus: A scoping review","volume":"17","author":"Cheong","year":"2024","journal-title":"J Foot Ankle Res"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-5491.2011.03539.x","article-title":"Recurrence of the acute Charcot foot in diabetes","volume":"29","author":"Rudrappa","year":"2012","journal-title":"Diabetes Med"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1097\/rlu.0b013e318292eecb","article-title":"A new natural history of Charcot foot: clinical evolution and final outcome of stage 0 Charcot neuroarthropathy in a tertiary referral diabetic foot clinic","volume":"38","author":"Ruotolo","year":"2013","journal-title":"Clin Nucl Med"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1007\/s00256-010-1092-0","article-title":"Role of dynamic MRI in the follow-up of acute Charcot foot in patients with diabetes mellitus","volume":"40","author":"Zampa","year":"2011","journal-title":"Skeletal Radiol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1186\/s13047-023-00601-7","article-title":"A randomised feasibility study of serial magnetic resonance imaging to reduce treatment times in Charcot neuroarthropathy in people with diabetes (CADOM)","volume":"16","author":"Gooday","year":"2023","journal-title":"J Foot Ankle Res"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1080\/2000625x.2018.1466611","article-title":"Follow up of MRI bone marrow edema in the treated diabetic Charcot foot - a review of patient charts","volume":"9","author":"Chantelau","year":"2018","journal-title":"Diabetes Foot Ankle"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1930281\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T04:28:11Z","timestamp":1790310491000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1930281\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,25]]},"references-count":31,"alternative-id":["10.3389\/fendo.2026.1930281"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1930281","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,25]]},"article-number":"1930281"}}